Single-probe Microwave Ablation (MWA) of Metastatic Liver Cancer
NCT ID: NCT00922181
Last Updated: 2009-11-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2008-08-31
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Percutaneous Microwave Ablation Under Ultrasound Guidance for Liver Cancer: a Multicenter Analysis
NCT03045952
Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation
NCT01340105
Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma
NCT06086002
Comparison of Microwave and Radiofrequency Ablation for Liver
NCT02539212
Clinical Effectiveness of Microwave Ablation Using Starwave Microwave Generator for Hepatic Malignancies
NCT06426992
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MWA
Patients undergoing MWA for hepatic metastases smaller than 3 cm, without underlying liver disease
Microwave ablation
Liver tumors are destructed/ablated using single-probe microwave energy device
RFA
Patients undergoing RFA for hepatic metastases smaller than 3 cm, without underlying liver disease
Radiofrequency ablation
Liver tumors are destructed/ablated using radiofrequency energy device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Microwave ablation
Liver tumors are destructed/ablated using single-probe microwave energy device
Radiofrequency ablation
Liver tumors are destructed/ablated using radiofrequency energy device
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No invasion of major biliary structures
* No invasion of major vascular structures
* ASA score \< 4
* WHO score 0-1
* Pre-operative chemotherapy is allowed
Exclusion Criteria
* Life expectancy less than 3 months
* Patients with cardiac pacemaker, cerebral aneurysm clips, implanted electronic instruments or other metal materials
* Coagulopathy with platelet count less than 50000
* Active infectious disease
* Age below 18 years
* Pregnancy of breastfeeding
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Gasthuisberg
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Baki Topal, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Universitaire Ziekenhuizen KU Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Gasthuisberg
Leuven, Vlaams-Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hompes R, Fieuws S, Aerts R, Thijs M, Penninckx F, Topal B. Results of single-probe microwave ablation of metastatic liver cancer. Eur J Surg Oncol. 2010 Aug;36(8):725-30. doi: 10.1016/j.ejso.2010.05.013. Epub 2010 Jun 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
kulasMWA1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.